Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor.
Chim
C-S
CS
Chan
W W-L
WW
Pang
A
A
Kwong
Y-L
YL
D048868:Adaptor Proteins, Signal Transducing; D001374:Azacitidine / Q000494:pharmacology; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D008745:Methylation; D015999:Multivariate Analysis; D011379:Prognosis; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D012008:Recurrence; D012074:Remission Induction; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D012307:Risk Factors; D012680:Sensitivity and Specificity; D015996:Survival Rate; D014212:Tretinoin / Q000627:therapeutic use; D014407:Tumor Cells, Cultured
D048868:Adaptor Proteins, Signal Transducing; D014408:Biomarkers, Tumor; D002352:Carrier Proteins; D012333:RNA, Messenger; D012097:Repressor Proteins; C485569:WIF1 protein, human; D014212:Tretinoin; D001374:Azacitidine